Loading...
XNAS
VANI
Market cap93mUSD
Jul 09, Last price  
1.56USD
1D
-2.50%
1Q
50.00%
Jan 2017
-96.70%
IPO
-99.72%
Name

Vivani Medical Inc

Chart & Performance

D1W1MN
XNAS:VANI chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
17.29%
Rev. gr., 5y
-14.98%
Revenues
0k
1,367,2241,564,9333,397,8528,950,0003,985,0007,964,0006,896,0003,379,000000000
Net income
-27m
L+13.30%
-16,279,127-22,968,925-35,201,247-20,018,000-33,179,000-28,516,000-35,094,000-33,592,000-9,279,000-12,773,000-13,889,000-25,652,000-23,486,000-26,609,000
CFO
-24m
L+17.00%
-15,321,214-17,426,862-17,092,342-20,549,000-25,070,000-23,947,000-29,810,000-27,629,000-7,619,000-10,951,000-18,787,000-23,699,000-20,786,000-24,320,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

EYEStargets pure-play or the top 10 companiesmaterially involved indeveloping and deploying technologies that collect, process, analyze, and operationalize data for monitoring, security, and operational visibility.The fund considers companies deriving significant revenue from this theme, spanningsensors, cameras, biometrics, identity verification, geospatial systems, enterprise analytics platforms, and privacy and governance technologies.Using a bottom-up approach that combines fundamental analysis with thematic and quantitative screening, the fund invests in US and international stocks of any market capitalization.Otherfactors include supply chain positioning, growth potential, and valuation.Up to 15% may beallocatedto illiquid investments, including passive minority interests inSPVs.Holdings may include cash, cash equivalents, or short-term US treasuries for liquidity or portfolio management.
IPO date
Nov 19, 2014
Employees
50
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT